What is Pharmaceutical Boric Acid Market?
Pharmaceutical boric acid is used as bacteriostats or mild antiseptics in eyewashes, burn dressings, mouthwashes, and diaper rash powders. It has antibacterial activity against infections such as candidiasis and bacterial vaginosis. It has various characteristics such as it is well absorbed from the open wounds, gastrointestinal tract, and serous cavities but displays limited absorption in intact skin. It is primarily used in aqueous solutions or powders for external use. The factors such as Increased Applications of Boric Acid for Antifungal and Antifungal Medications and High Demand for Antiseptic Medications are driving the factors for the global pharmaceutical boric acid market.
The market study is being classified, by Application (Antifungal and Antibacterial) and major geographies with country level break-up.
3M (United States), BASF SE (Germany), U.S. Borax Inc. (United States), Gujarat Boron Derivatives Pvt. Ltd. (India), Eti Mine Works (Turkey), KRG International (India), Hebei Huachen Pharmaceutical Co., Ltd. (China), Euro Industrial Chemicals (Kenya) and MilliporeSigma (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Anmol Chemicals (India) and Organic Industries Ltd. (India).
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that Global Players will contribute to the maximum growth of Global Pharmaceutical Boric Acid market throughout the predicted period.
Segment Analysis
Analyst at AMA have segmented the market study of Global Pharmaceutical Boric Acid market by Type, Application and Region.
On the basis of geography, the market of Pharmaceutical Boric Acid has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Increased Applications of Boric Acid for Antifungal and Antifungal Medications
- High Demand for Antiseptic Medications
Market Trend
- Increased Research and Development Activities
- Rapid Advancements in the Medical Science
Restraints
- Side Effects of the Boric Acid
Opportunities
- Robust Increase in the Distribution Channels
- Growth in the Pharmaceutical Industry Worldwide
Challenges
- High Cost of Research and Development Activities
In May 2019, 3M Co. agreed to buy medical-products maker Acelity Inc., its biggest acquisition ever, as new Chief Executive Officer Mike Roman takes a more aggressive approach to expand the beleaguered company.
Key Target Audience
Pharmaceutical Boric Acid Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies and End-users